Market closedADR
Bicycle Therapeutics/$BCYC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bicycle Therapeutics
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
Ticker
$BCYC
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
305
ISIN
US0887861088
Website
BCYC Metrics
BasicAdvanced
$566M
-
-$3.14
-
-
Price and volume
Market cap
$566M
52-week high
$27.11
52-week low
$6.10
Average daily volume
425K
Financial strength
Current ratio
14.857
Quick ratio
14.566
Long term debt to equity
0.352
Total debt to equity
0.352
Interest coverage (TTM)
-258.71%
Management effectiveness
Return on assets (TTM)
-21.69%
Return on equity (TTM)
-37.07%
Valuation
Price to revenue (TTM)
20.629
Price to book
0.76
Price to tangible book (TTM)
0.76
Price to free cash flow (TTM)
-2.915
Growth
Revenue change (TTM)
-38.18%
Earnings per share change (TTM)
-27.73%
3-year revenue growth (CAGR)
23.22%
3-year earnings per share growth (CAGR)
2.63%
What the Analysts think about BCYC
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Bicycle Therapeutics stock.
BCYC Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
BCYC Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
BCYC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bicycle Therapeutics stock?
Bicycle Therapeutics (BCYC) has a market cap of $566M as of May 10, 2025.
What is the P/E ratio for Bicycle Therapeutics stock?
The price to earnings (P/E) ratio for Bicycle Therapeutics (BCYC) stock is 0 as of May 10, 2025.
Does Bicycle Therapeutics stock pay dividends?
No, Bicycle Therapeutics (BCYC) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Bicycle Therapeutics dividend payment date?
Bicycle Therapeutics (BCYC) stock does not pay dividends to its shareholders.
What is the beta indicator for Bicycle Therapeutics?
Bicycle Therapeutics (BCYC) does not currently have a Beta indicator.